LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis
T. Xu, C.-L. Liu, T. Li, Y.-H. Zhang, Y.-H. Zhao Department of Urology, Qingdao Central Hospital, Qingdao, China
The article “LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis, by T. Xu, C.-L. Liu, T. Li, Y.-H. Zhang, Y.-H. Zhao, published in Eur Rev Med Pharmacol Sci 2019; 23 (11): 4698-4705–DOI: 10.26355/eurrev_201906_18062–PMID: 31210308” has been retracted by the authors as they state that due to a larger sample size, their new experimental results are inconsistent with the data showed in Figure 1B of the manuscript.
The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadLncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
T. Xu, C.-L. Liu, T. Li, Y.-H. Zhang, Y.-H. Zhao
LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis
Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 9
Pages: 3057-3057
DOI: 10.26355/eurrev_202205_28719
Publication History
Published online: 13 May 2022